nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—ALB—Estropipate—osteoporosis	0.189	0.267	CbGbCtD
MACITENTAN—ALB—Estradiol—osteoporosis	0.0785	0.111	CbGbCtD
MACITENTAN—CYP2C19—Cholecalciferol—osteoporosis	0.0632	0.0891	CbGbCtD
MACITENTAN—CYP3A4—Estropipate—osteoporosis	0.0593	0.0836	CbGbCtD
MACITENTAN—CYP3A4—Calcitriol—osteoporosis	0.0593	0.0836	CbGbCtD
MACITENTAN—CYP2C19—Estradiol—osteoporosis	0.0509	0.0719	CbGbCtD
MACITENTAN—CYP3A4—Ergocalciferol—osteoporosis	0.0474	0.0669	CbGbCtD
MACITENTAN—CYP3A4—Raloxifene—osteoporosis	0.0395	0.0558	CbGbCtD
MACITENTAN—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0382	0.0539	CbGbCtD
MACITENTAN—CYP3A4—Cholecalciferol—osteoporosis	0.0305	0.0431	CbGbCtD
MACITENTAN—CYP3A4—Conjugated Estrogens—osteoporosis	0.028	0.0396	CbGbCtD
MACITENTAN—CYP3A4—Estradiol—osteoporosis	0.0246	0.0347	CbGbCtD
MACITENTAN—Fluid retention—Estropipate—osteoporosis	0.00402	0.0218	CcSEcCtD
MACITENTAN—Fluid retention—Ethinyl Estradiol—osteoporosis	0.00326	0.0176	CcSEcCtD
MACITENTAN—Anaemia—Ergocalciferol—osteoporosis	0.00266	0.0144	CcSEcCtD
MACITENTAN—Oedema—Calcium Acetate—osteoporosis	0.00266	0.0144	CcSEcCtD
MACITENTAN—Influenza—Estropipate—osteoporosis	0.00266	0.0144	CcSEcCtD
MACITENTAN—Fluid retention—Conjugated Estrogens—osteoporosis	0.00266	0.0144	CcSEcCtD
MACITENTAN—Nasopharyngitis—Ibandronate—osteoporosis	0.00264	0.0143	CcSEcCtD
MACITENTAN—Nasopharyngitis—Calcitriol—osteoporosis	0.00258	0.014	CcSEcCtD
MACITENTAN—Influenza—Raloxifene—osteoporosis	0.00257	0.0139	CcSEcCtD
MACITENTAN—Influenza—Ibandronate—osteoporosis	0.00255	0.0138	CcSEcCtD
MACITENTAN—Hypotension—Calcium Acetate—osteoporosis	0.00249	0.0135	CcSEcCtD
MACITENTAN—Bronchitis—Raloxifene—osteoporosis	0.00248	0.0134	CcSEcCtD
MACITENTAN—Bronchitis—Ibandronate—osteoporosis	0.00245	0.0133	CcSEcCtD
MACITENTAN—Infestation NOS—Estropipate—osteoporosis	0.00237	0.0128	CcSEcCtD
MACITENTAN—Infestation—Estropipate—osteoporosis	0.00237	0.0128	CcSEcCtD
MACITENTAN—Infestation NOS—Ibandronate—osteoporosis	0.00227	0.0123	CcSEcCtD
MACITENTAN—Infestation—Ibandronate—osteoporosis	0.00227	0.0123	CcSEcCtD
MACITENTAN—Urinary tract infection—Raloxifene—osteoporosis	0.00223	0.0121	CcSEcCtD
MACITENTAN—Urinary tract infection—Ibandronate—osteoporosis	0.00221	0.012	CcSEcCtD
MACITENTAN—Nasopharyngitis—Risedronate—osteoporosis	0.00217	0.0118	CcSEcCtD
MACITENTAN—Urinary tract infection—Calcitriol—osteoporosis	0.00216	0.0117	CcSEcCtD
MACITENTAN—Fluid retention—Estradiol—osteoporosis	0.00213	0.0115	CcSEcCtD
MACITENTAN—Pharyngitis—Estropipate—osteoporosis	0.00211	0.0114	CcSEcCtD
MACITENTAN—Influenza—Risedronate—osteoporosis	0.0021	0.0114	CcSEcCtD
MACITENTAN—Bronchitis—Ethinyl Estradiol—osteoporosis	0.00207	0.0112	CcSEcCtD
MACITENTAN—Nasopharyngitis—Pamidronate—osteoporosis	0.00207	0.0112	CcSEcCtD
MACITENTAN—Pharyngitis—Raloxifene—osteoporosis	0.00204	0.0111	CcSEcCtD
MACITENTAN—Pharyngitis—Ibandronate—osteoporosis	0.00202	0.011	CcSEcCtD
MACITENTAN—Bronchitis—Risedronate—osteoporosis	0.00202	0.0109	CcSEcCtD
MACITENTAN—Influenza—Pamidronate—osteoporosis	0.002	0.0108	CcSEcCtD
MACITENTAN—Anaemia—Etidronic acid—osteoporosis	0.00198	0.0107	CcSEcCtD
MACITENTAN—Angiopathy—Estropipate—osteoporosis	0.00193	0.0104	CcSEcCtD
MACITENTAN—Infestation NOS—Ethinyl Estradiol—osteoporosis	0.00192	0.0104	CcSEcCtD
MACITENTAN—Infestation—Ethinyl Estradiol—osteoporosis	0.00192	0.0104	CcSEcCtD
MACITENTAN—Nasopharyngitis—Zoledronate—osteoporosis	0.00189	0.0102	CcSEcCtD
MACITENTAN—Infestation NOS—Risedronate—osteoporosis	0.00187	0.0101	CcSEcCtD
MACITENTAN—Infestation—Risedronate—osteoporosis	0.00187	0.0101	CcSEcCtD
MACITENTAN—Angiopathy—Raloxifene—osteoporosis	0.00187	0.0101	CcSEcCtD
MACITENTAN—Urinary tract infection—Ethinyl Estradiol—osteoporosis	0.00187	0.0101	CcSEcCtD
MACITENTAN—Angiopathy—Ibandronate—osteoporosis	0.00185	0.01	CcSEcCtD
MACITENTAN—Influenza—Zoledronate—osteoporosis	0.00182	0.00987	CcSEcCtD
MACITENTAN—Urinary tract infection—Risedronate—osteoporosis	0.00182	0.00985	CcSEcCtD
MACITENTAN—Infestation—Pamidronate—osteoporosis	0.00178	0.00964	CcSEcCtD
MACITENTAN—Infestation NOS—Pamidronate—osteoporosis	0.00178	0.00964	CcSEcCtD
MACITENTAN—Influenza—Conjugated Estrogens—osteoporosis	0.00176	0.00951	CcSEcCtD
MACITENTAN—Infection—Etidronic acid—osteoporosis	0.00174	0.0094	CcSEcCtD
MACITENTAN—Urinary tract infection—Pamidronate—osteoporosis	0.00173	0.00937	CcSEcCtD
MACITENTAN—Pharyngitis—Ethinyl Estradiol—osteoporosis	0.00171	0.00926	CcSEcCtD
MACITENTAN—Bronchitis—Conjugated Estrogens—osteoporosis	0.00169	0.00914	CcSEcCtD
MACITENTAN—Anaemia—Alendronate—osteoporosis	0.00169	0.00913	CcSEcCtD
MACITENTAN—Pharyngitis—Risedronate—osteoporosis	0.00167	0.00903	CcSEcCtD
MACITENTAN—Anaemia—Ibandronate—osteoporosis	0.00164	0.00889	CcSEcCtD
MACITENTAN—Infestation—Zoledronate—osteoporosis	0.00163	0.0088	CcSEcCtD
MACITENTAN—Infestation NOS—Zoledronate—osteoporosis	0.00163	0.0088	CcSEcCtD
MACITENTAN—Urinary tract infection—Zoledronate—osteoporosis	0.00158	0.00856	CcSEcCtD
MACITENTAN—Infestation—Conjugated Estrogens—osteoporosis	0.00157	0.00848	CcSEcCtD
MACITENTAN—Infestation NOS—Conjugated Estrogens—osteoporosis	0.00157	0.00848	CcSEcCtD
MACITENTAN—Angiopathy—Ethinyl Estradiol—osteoporosis	0.00156	0.00847	CcSEcCtD
MACITENTAN—Angiopathy—Risedronate—osteoporosis	0.00153	0.00826	CcSEcCtD
MACITENTAN—Oedema—Estropipate—osteoporosis	0.00151	0.00818	CcSEcCtD
MACITENTAN—Infection—Estropipate—osteoporosis	0.0015	0.00813	CcSEcCtD
MACITENTAN—Nervous system disorder—Estropipate—osteoporosis	0.00148	0.00802	CcSEcCtD
MACITENTAN—Infection—Alendronate—osteoporosis	0.00148	0.00801	CcSEcCtD
MACITENTAN—Infection—Raloxifene—osteoporosis	0.00145	0.00787	CcSEcCtD
MACITENTAN—Nasopharyngitis—Estradiol—osteoporosis	0.00145	0.00787	CcSEcCtD
MACITENTAN—Angiopathy—Pamidronate—osteoporosis	0.00145	0.00785	CcSEcCtD
MACITENTAN—Infection—Ibandronate—osteoporosis	0.00144	0.00779	CcSEcCtD
MACITENTAN—Nervous system disorder—Raloxifene—osteoporosis	0.00144	0.00777	CcSEcCtD
MACITENTAN—Nervous system disorder—Ibandronate—osteoporosis	0.00142	0.00769	CcSEcCtD
MACITENTAN—Influenza—Estradiol—osteoporosis	0.00141	0.00761	CcSEcCtD
MACITENTAN—Pharyngitis—Conjugated Estrogens—osteoporosis	0.00139	0.00755	CcSEcCtD
MACITENTAN—Anaemia—Risedronate—osteoporosis	0.00135	0.00732	CcSEcCtD
MACITENTAN—Bronchitis—Estradiol—osteoporosis	0.00135	0.00732	CcSEcCtD
MACITENTAN—Angiopathy—Zoledronate—osteoporosis	0.00132	0.00717	CcSEcCtD
MACITENTAN—Anaemia—Pamidronate—osteoporosis	0.00129	0.00696	CcSEcCtD
MACITENTAN—Angiopathy—Conjugated Estrogens—osteoporosis	0.00128	0.0069	CcSEcCtD
MACITENTAN—Infestation—Estradiol—osteoporosis	0.00125	0.00678	CcSEcCtD
MACITENTAN—Infestation NOS—Estradiol—osteoporosis	0.00125	0.00678	CcSEcCtD
MACITENTAN—Oedema—Ethinyl Estradiol—osteoporosis	0.00122	0.00663	CcSEcCtD
MACITENTAN—Urinary tract infection—Estradiol—osteoporosis	0.00122	0.00659	CcSEcCtD
MACITENTAN—Infection—Ethinyl Estradiol—osteoporosis	0.00122	0.00659	CcSEcCtD
MACITENTAN—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.0012	0.0065	CcSEcCtD
MACITENTAN—Infection—Risedronate—osteoporosis	0.00119	0.00642	CcSEcCtD
MACITENTAN—Anaemia—Zoledronate—osteoporosis	0.00117	0.00636	CcSEcCtD
MACITENTAN—Nervous system disorder—Risedronate—osteoporosis	0.00117	0.00634	CcSEcCtD
MACITENTAN—Oedema—Pamidronate—osteoporosis	0.00114	0.00615	CcSEcCtD
MACITENTAN—Infection—Pamidronate—osteoporosis	0.00113	0.00611	CcSEcCtD
MACITENTAN—Pharyngitis—Estradiol—osteoporosis	0.00112	0.00604	CcSEcCtD
MACITENTAN—Nervous system disorder—Pamidronate—osteoporosis	0.00111	0.00603	CcSEcCtD
MACITENTAN—Headache—Etidronic acid—osteoporosis	0.00109	0.00592	CcSEcCtD
MACITENTAN—Hypotension—Pamidronate—osteoporosis	0.00106	0.00574	CcSEcCtD
MACITENTAN—Oedema—Zoledronate—osteoporosis	0.00104	0.00561	CcSEcCtD
MACITENTAN—Infection—Zoledronate—osteoporosis	0.00103	0.00558	CcSEcCtD
MACITENTAN—Angiopathy—Estradiol—osteoporosis	0.00102	0.00553	CcSEcCtD
MACITENTAN—Nervous system disorder—Zoledronate—osteoporosis	0.00102	0.00551	CcSEcCtD
MACITENTAN—Oedema—Conjugated Estrogens—osteoporosis	0.000998	0.00541	CcSEcCtD
MACITENTAN—Infection—Conjugated Estrogens—osteoporosis	0.000992	0.00537	CcSEcCtD
MACITENTAN—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000979	0.0053	CcSEcCtD
MACITENTAN—Hypotension—Zoledronate—osteoporosis	0.000969	0.00525	CcSEcCtD
MACITENTAN—Headache—Estropipate—osteoporosis	0.000947	0.00513	CcSEcCtD
MACITENTAN—Hypotension—Conjugated Estrogens—osteoporosis	0.000933	0.00505	CcSEcCtD
MACITENTAN—Headache—Alendronate—osteoporosis	0.000932	0.00505	CcSEcCtD
MACITENTAN—Headache—Raloxifene—osteoporosis	0.000917	0.00497	CcSEcCtD
MACITENTAN—Headache—Ibandronate—osteoporosis	0.000908	0.00492	CcSEcCtD
MACITENTAN—Headache—Calcitriol—osteoporosis	0.000889	0.00481	CcSEcCtD
MACITENTAN—Oedema—Estradiol—osteoporosis	0.000799	0.00433	CcSEcCtD
MACITENTAN—Infection—Estradiol—osteoporosis	0.000794	0.0043	CcSEcCtD
MACITENTAN—Nervous system disorder—Estradiol—osteoporosis	0.000784	0.00424	CcSEcCtD
MACITENTAN—Headache—Ethinyl Estradiol—osteoporosis	0.000767	0.00415	CcSEcCtD
MACITENTAN—Headache—Risedronate—osteoporosis	0.000748	0.00405	CcSEcCtD
MACITENTAN—Headache—Pamidronate—osteoporosis	0.000711	0.00385	CcSEcCtD
MACITENTAN—Headache—Zoledronate—osteoporosis	0.00065	0.00352	CcSEcCtD
MACITENTAN—Headache—Conjugated Estrogens—osteoporosis	0.000625	0.00339	CcSEcCtD
MACITENTAN—Headache—Estradiol—osteoporosis	0.000501	0.00271	CcSEcCtD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000306	0.00286	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000304	0.00284	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000293	0.00274	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—WNT1—osteoporosis	0.000291	0.00273	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—PTHLH—osteoporosis	0.00029	0.00272	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—SOD2—osteoporosis	0.000288	0.0027	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MGLL—osteoporosis	0.000284	0.00266	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SOST—osteoporosis	0.000283	0.00265	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.00028	0.00262	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—LRP5—osteoporosis	0.000277	0.0026	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—GPX1—osteoporosis	0.000275	0.00257	CbGpPWpGaD
MACITENTAN—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000271	0.00254	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	0.000268	0.00251	CbGpPWpGaD
MACITENTAN—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000265	0.00248	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—LRP6—osteoporosis	0.000265	0.00248	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	0.000265	0.00248	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PTHLH—osteoporosis	0.000264	0.00247	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CALCR—osteoporosis	0.000256	0.0024	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTH1R—osteoporosis	0.000256	0.0024	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CALCA—osteoporosis	0.000255	0.00239	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—MTHFR—osteoporosis	0.000254	0.00238	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—WDR1—osteoporosis	0.000251	0.00235	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—PTH—osteoporosis	0.000251	0.00235	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CNR2—osteoporosis	0.000244	0.00229	CbGpPWpGaD
MACITENTAN—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000243	0.00228	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000241	0.00226	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000238	0.00223	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—POMC—osteoporosis	0.000237	0.00221	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CALCA—osteoporosis	0.000232	0.00217	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	0.000229	0.00214	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PTH—osteoporosis	0.000228	0.00213	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TLN1—osteoporosis	0.000224	0.0021	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000222	0.00208	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CNR2—osteoporosis	0.000222	0.00208	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	0.000218	0.00205	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—WNT1—osteoporosis	0.000209	0.00195	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—PTHLH—osteoporosis	0.000208	0.00194	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MGLL—osteoporosis	0.000203	0.0019	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000202	0.00189	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.0002	0.00187	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000199	0.00186	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—LRP5—osteoporosis	0.000198	0.00186	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—CAP1—osteoporosis	0.000198	0.00186	CbGpPWpGaD
MACITENTAN—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000197	0.00184	CbGpPWpGaD
MACITENTAN—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000197	0.00184	CbGpPWpGaD
MACITENTAN—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000194	0.00182	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—P4HB—osteoporosis	0.000193	0.00181	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—LRP6—osteoporosis	0.00019	0.00178	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000189	0.00177	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PTHLH—osteoporosis	0.000189	0.00177	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PTH—osteoporosis	0.000188	0.00176	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	0.000185	0.00173	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—RAP1A—osteoporosis	0.000185	0.00173	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CNR2—osteoporosis	0.000183	0.00171	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CALCA—osteoporosis	0.000183	0.00171	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000182	0.00171	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—ADCY5—osteoporosis	0.000182	0.0017	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.00018	0.00169	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NFATC1—osteoporosis	0.00018	0.00169	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000179	0.00168	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—DKK1—osteoporosis	0.000179	0.00167	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—WNT1—osteoporosis	0.000172	0.00161	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00017	0.00159	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—POMC—osteoporosis	0.000169	0.00158	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—FGA—osteoporosis	0.000167	0.00157	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—IGF1—osteoporosis	0.000167	0.00157	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CALCA—osteoporosis	0.000166	0.00155	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—ADCY5—osteoporosis	0.000165	0.00155	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000164	0.00154	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000161	0.00151	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TLN1—osteoporosis	0.00016	0.0015	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00016	0.00149	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000159	0.00149	CbGpPWpGaD
MACITENTAN—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000159	0.00149	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000159	0.00149	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MGLL—osteoporosis	0.000158	0.00148	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PTHLH—osteoporosis	0.000156	0.00146	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—BMP2—osteoporosis	0.000156	0.00146	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—FGB—osteoporosis	0.000152	0.00143	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL1B—osteoporosis	0.000151	0.00141	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000147	0.00138	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PSMA2—osteoporosis	0.000147	0.00138	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PSMA5—osteoporosis	0.000147	0.00138	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PLEK—osteoporosis	0.000144	0.00135	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—ANXA2—osteoporosis	0.000144	0.00135	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000144	0.00134	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	0.000141	0.00132	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	0.000139	0.0013	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—P4HB—osteoporosis	0.000138	0.00129	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CALCA—osteoporosis	0.000137	0.00128	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTH—osteoporosis	0.000134	0.00126	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	0.000134	0.00126	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—POMC—osteoporosis	0.000134	0.00125	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000132	0.00124	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RAP1A—osteoporosis	0.000132	0.00124	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CNR2—osteoporosis	0.000131	0.00123	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.00013	0.00122	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—ADCY5—osteoporosis	0.00013	0.00122	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NFATC1—osteoporosis	0.000129	0.00121	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000129	0.00121	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—DKK1—osteoporosis	0.000128	0.0012	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000125	0.00117	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—KL—osteoporosis	0.000124	0.00117	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TLN1—osteoporosis	0.000124	0.00116	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—WNT1—osteoporosis	0.000123	0.00115	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—VCL—osteoporosis	0.000123	0.00115	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—POMC—osteoporosis	0.000121	0.00114	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—FGA—osteoporosis	0.00012	0.00112	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	0.00012	0.00112	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL6R—osteoporosis	0.000118	0.00111	CbGpPWpGaD
MACITENTAN—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000118	0.00111	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—ADCY5—osteoporosis	0.000118	0.00111	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000115	0.00107	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTHLH—osteoporosis	0.000111	0.00104	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—BMP2—osteoporosis	0.000111	0.00104	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TNF—osteoporosis	0.000109	0.00102	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—FGB—osteoporosis	0.000109	0.00102	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	0.000108	0.00101	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PSMA2—osteoporosis	0.000105	0.000985	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PSMA5—osteoporosis	0.000105	0.000985	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000103	0.000964	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—RAP1A—osteoporosis	0.000102	0.000959	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—TGFB1—osteoporosis	0.0001	0.00094	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CALCA—osteoporosis	9.81e-05	0.000918	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.76e-05	0.000913	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ADCY5—osteoporosis	9.75e-05	0.000913	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.59e-05	0.000897	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—POMC—osteoporosis	9.57e-05	0.000896	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	9.56e-05	0.000895	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—SPP1—osteoporosis	9.43e-05	0.000883	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—FGA—osteoporosis	9.29e-05	0.00087	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—KL—osteoporosis	8.91e-05	0.000834	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PKM—osteoporosis	8.9e-05	0.000833	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—FDPS—osteoporosis	8.9e-05	0.000833	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL6—osteoporosis	8.82e-05	0.000826	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.76e-05	0.00082	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—POMC—osteoporosis	8.69e-05	0.000813	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—TNF—osteoporosis	8.68e-05	0.000813	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IRS2—osteoporosis	8.53e-05	0.000799	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL6R—osteoporosis	8.47e-05	0.000793	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	8.47e-05	0.000793	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—POMC—osteoporosis	8.47e-05	0.000793	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—FGB—osteoporosis	8.45e-05	0.000791	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PGLS—osteoporosis	8.43e-05	0.00079	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GPD2—osteoporosis	8.43e-05	0.00079	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	8.36e-05	0.000782	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—LEP—osteoporosis	8.35e-05	0.000781	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—FDPS—osteoporosis	7.99e-05	0.000748	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PKM—osteoporosis	7.99e-05	0.000748	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ESR1—osteoporosis	7.97e-05	0.000746	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ATIC—osteoporosis	7.71e-05	0.000722	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PNP—osteoporosis	7.71e-05	0.000722	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PGLS—osteoporosis	7.57e-05	0.000709	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GPD2—osteoporosis	7.57e-05	0.000709	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IRS1—osteoporosis	7.45e-05	0.000697	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	7.42e-05	0.000695	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—POMC—osteoporosis	7.17e-05	0.000671	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IL6—osteoporosis	7.01e-05	0.000656	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL6R—osteoporosis	6.99e-05	0.000655	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ADCY5—osteoporosis	6.98e-05	0.000653	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ATIC—osteoporosis	6.92e-05	0.000648	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PNP—osteoporosis	6.92e-05	0.000648	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IGF1—osteoporosis	6.9e-05	0.000646	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SPP1—osteoporosis	6.75e-05	0.000632	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—OXCT1—osteoporosis	6.56e-05	0.000614	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CA2—osteoporosis	6.56e-05	0.000614	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—MGLL—osteoporosis	6.39e-05	0.000598	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IRS2—osteoporosis	6.1e-05	0.000572	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.03e-05	0.000564	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—LEP—osteoporosis	5.97e-05	0.000559	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—OXCT1—osteoporosis	5.89e-05	0.000551	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CA2—osteoporosis	5.89e-05	0.000551	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—MGLL—osteoporosis	5.74e-05	0.000537	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ESR1—osteoporosis	5.7e-05	0.000534	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—IDH2—osteoporosis	5.43e-05	0.000509	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.41e-05	0.000507	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IRS1—osteoporosis	5.33e-05	0.000499	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL6—osteoporosis	5.27e-05	0.000494	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—POMC—osteoporosis	5.13e-05	0.00048	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP27A1—osteoporosis	5.11e-05	0.000478	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—POMC—osteoporosis	5.09e-05	0.000477	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL6R—osteoporosis	5.01e-05	0.000469	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ACP5—osteoporosis	4.97e-05	0.000465	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IGF1—osteoporosis	4.94e-05	0.000462	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.91e-05	0.000459	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—IDH2—osteoporosis	4.88e-05	0.000457	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—FDPS—osteoporosis	4.8e-05	0.00045	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PKM—osteoporosis	4.8e-05	0.00045	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.68e-05	0.000438	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—TPI1—osteoporosis	4.62e-05	0.000433	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP27A1—osteoporosis	4.59e-05	0.000429	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GPD2—osteoporosis	4.55e-05	0.000426	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PGLS—osteoporosis	4.55e-05	0.000426	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ACP5—osteoporosis	4.46e-05	0.000418	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	4.45e-05	0.000417	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.41e-05	0.000412	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—P4HB—osteoporosis	4.34e-05	0.000407	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GAPDH—osteoporosis	4.26e-05	0.000399	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ATIC—osteoporosis	4.16e-05	0.00039	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PNP—osteoporosis	4.16e-05	0.00039	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—RAP1A—osteoporosis	4.15e-05	0.000389	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—TPI1—osteoporosis	4.15e-05	0.000388	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MYC—osteoporosis	4.15e-05	0.000388	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TGFB1—osteoporosis	4.14e-05	0.000387	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—P4HB—osteoporosis	3.9e-05	0.000365	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GAPDH—osteoporosis	3.83e-05	0.000358	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IGF1—osteoporosis	3.83e-05	0.000358	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL6—osteoporosis	3.78e-05	0.000353	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—RAP1A—osteoporosis	3.73e-05	0.000349	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.62e-05	0.000339	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CA2—osteoporosis	3.54e-05	0.000331	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—OXCT1—osteoporosis	3.54e-05	0.000331	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—MGLL—osteoporosis	3.45e-05	0.000323	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ENO1—osteoporosis	3.36e-05	0.000314	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PSMA2—osteoporosis	3.31e-05	0.00031	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PSMA5—osteoporosis	3.31e-05	0.00031	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.25e-05	0.000304	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL6—osteoporosis	3.12e-05	0.000292	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ENO1—osteoporosis	3.01e-05	0.000282	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PSMA2—osteoporosis	2.97e-05	0.000278	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PSMA5—osteoporosis	2.97e-05	0.000278	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MYC—osteoporosis	2.97e-05	0.000278	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TGFB1—osteoporosis	2.96e-05	0.000277	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—IDH2—osteoporosis	2.93e-05	0.000275	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.76e-05	0.000258	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP19A1—osteoporosis	2.68e-05	0.000251	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ACP5—osteoporosis	2.68e-05	0.000251	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—TPI1—osteoporosis	2.49e-05	0.000234	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP19A1—osteoporosis	2.41e-05	0.000226	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—P4HB—osteoporosis	2.35e-05	0.00022	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GAPDH—osteoporosis	2.3e-05	0.000216	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TGFB1—osteoporosis	2.29e-05	0.000215	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—RAP1A—osteoporosis	2.24e-05	0.00021	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL6—osteoporosis	2.23e-05	0.000209	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ADCY5—osteoporosis	2.19e-05	0.000205	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GPX1—osteoporosis	2.19e-05	0.000205	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—MTHFR—osteoporosis	2.02e-05	0.000189	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ADCY5—osteoporosis	1.97e-05	0.000184	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GPX1—osteoporosis	1.96e-05	0.000184	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ENO1—osteoporosis	1.81e-05	0.00017	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—MTHFR—osteoporosis	1.81e-05	0.00017	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PSMA2—osteoporosis	1.79e-05	0.000167	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PSMA5—osteoporosis	1.79e-05	0.000167	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—POMC—osteoporosis	1.61e-05	0.000151	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.45e-05	0.000136	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—POMC—osteoporosis	1.45e-05	0.000136	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ADCY5—osteoporosis	1.18e-05	0.000111	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GPX1—osteoporosis	1.18e-05	0.00011	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—MTHFR—osteoporosis	1.09e-05	0.000102	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—POMC—osteoporosis	8.71e-06	8.15e-05	CbGpPWpGaD
